Navigation Links
Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries
Date:12/12/2012

NEW YORK, Dec. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries

http://www.reportlinker.com/p01051675/Joint-Reconstruction-Hip-and-Knee-Devices-Market-to-2018---Advanced-Implant-Materials-Innovative-Designs-and-Improved-Longevity-lead-to-Rise-in-the-Number-of-Early-Joint-Replacement-Surgeries.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries

Summary GBI Research's report, "Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries" provides key data, information and analysis for the global joint reconstruction - hip and knee devices market. It examines the market and competitive landscape and trends for the knee reconstruction and hip reconstruction segments and provides comprehensive information on key trends and dynamics. The report also looks at the pipeline products in each segment and gives details of important M&A activity. It has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry expertsScope - Key market g
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Le Dr Beau Lotto se joint aux grands penseurs à loccasion du débat sur linnovation 2012
2. Le professeur Brian Cox se joint aux grands penseurs à loccasion du débat sur linnovation 2012
3. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
4. New Total Joint Replacement Registry From Remedy Informatics Aims to Enable Orthopedic Outcomes Research and Improve Quality for Hospitals and Orthopedic Surgery Groups
5. Monitor Clipper Partners and Augusto Orsini Jointly Acquire International Medical Products Consortium Sengewald Klinikprodukte GmbH
6. The Sino-Foreign Joint-Venture TEDA Puhua Hospital Established in Tianjin
7. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
8. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
9. Prime Healthcare Hospitals Ranked as "Top Performers" by The Joint Commission
10. Heart Failure Society of America And The American Association of Heart Failure Nurses Release Joint Statement
11. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... April 14, 2011 Oxford Finance Corporation (Oxford), a ... a $2 million equipment loan with Synta Pharmaceuticals Corp. ... compounds for use in Synta,s ongoing clinical trials in ... "Synta Pharmaceuticals has a diverse drug pipeline, including ...
... (NYSE: BT ) shared its vision of ... cloud computing strategies to pharma research at the Bio-IT ... This vision reflects BT,s strong capabilities and increasing specialization ... world,s leading pharmaceutical companies rely on BT to support ...
Cached Medicine Technology:Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp. 2BT Pushes for R&D Innovation at Bio-IT World Conference 2BT Pushes for R&D Innovation at Bio-IT World Conference 3
(Date:8/29/2014)... yesterday by the Mental Health Commission of Canada ... and education that police personnel receive. , "People ... Canada,s police community, and today,s report builds on ... people with mental illnesses," says Queen,s adjunct professor ... in the area of police psychology. "This is ...
(Date:8/29/2014)... New York, New York (PRWEB) August 29, 2014 ... died from cardiac arrest following a series of dialysis ... that alleges her death was the result of ... Liebhard LLP reports. The family’s lawsuit, which was file ... 2014, claims that the use of the products resulted ...
(Date:8/29/2014)... A team of scientists from the University of Colorado ... a process to expand production of stem cells used ... that extend beyond cancer, including treatments for inborn immunodeficiency ... article published Aug. 29 in PLOS ONE ... Regenerative Medicine and Stem Cell Biology and Taiga Biotechnologies, ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... 2014 LiveOps, Inc., the global leader ... announced that LiveOps has been selected as a call ... of Strength Telethon for the third year in a ... awareness to support MDA’s mission to help children and ... fatal muscle disease. This year’s program includes performances by ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4
... , , SAN FRANCISCO, Sept. 22 ... will be a key driver of economic growth in the state over ... almost 1 million workers with a collective earning power of more than ... on whether California,s education system will be able to provide enough health ...
... Finding explains why obese children have higher relapse rates, ... Leukemia cells can hide in fat tissue to evade ... are more likely to develop chemotherapy resistance and have ... found that obese children with leukemia are 50 percent ...
... take into account side effects, researchers say , TUESDAY, ... advanced prostate cancer can increase the risk of heart ... be safer than others, new research has found. , ... advanced prostate cancer or prostate cancer that had spread ...
... Role of Innovation in Global Public Health , , ... Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and ... research can improve health care across the U.S. and around the world. ... M.D., founder of Biogen and a member of the Prix Galien USA ...
... 22 The Neuropathy Association has announced two awardees ... , Every year, The Neuropathy Association--the leading ... neuropathies--awards two scientific research grants, each for $80,000 over ... This year,s grant recipients--Dennis Paul, Ph.D. and co-principal investigator, ...
... , Surgeons Urge Prompt Treatment for Growth Plate ... and outdoors, youth athletes stay active year-round in competitive sports, and for many ... American College of Foot and Ankle Surgeons advises that when a child complains ... warning sign of a serious foot problem. , , ...
Cached Medicine News:Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 2Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 3Health News:Leukemia Cells May Hide in Fat Tissue 2Health News:Hormone Therapy for Prostate Cancer Raises Heart Risks 2Health News:Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech 2Health News:Neuropathy Association Research Grants Advance the Understanding of Diabetic Neuropathy and Autoimmune Neuropathies 2Health News:Heel Pain in Youth Athletes: A Warning Sign 2
Futuremeds Astotherm Plus Blood and Fluid Warmers meet American Blood Bank and ECRI standards., ,Astotherm is a durable warmer you can rely on for many years....
... anesthesia solution for the MRI environment , ... ,The Narkomed MRI-2 is the only ... monitor, designed and engineered to perform, without distance ... environments of up to 3.0 Tesla. This feature ...
... Narkomed GS provides high quality ventilation ... The proven technologies of the AV2+ ... the Narkomed GS user-friendly and intuitive. ... quality Narkomed GS is the perfect ...
... facilities where space is a premium Fabius ... delivery technologies with an ergonomic and compact ... of the Draeger Infinity patient monitoring range ... environment that is a sound investment into ...
Medicine Products: